In the semaglutide arm, risk fell by about 4% per 5 kg lower baseline weight (HR 0.96), whereas this trend was not significant in the placebo arm
Plaintiffs may now proceed with cases involving: Vision injuries , including Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Gastroparesis confirmed through objective diagnostic tests such as scintigraphy, breath testing, or wireless motility capsule (WMC) studies The JPML reported that as of September 2, 2025, there are 2,676 actions pending in the Ozempic lawsuit MDL
"I actually think it must be annoying how confident I am at the moment," Jess laughs
Aligning behavior change with values Therapy helps you clarify what kind of life you want after GLP-1s often including energy, flexibility, mental peace, social connection, and physical health